25193-53-7

Basic information

• Product Name: PANOSE
• Synonyms: D-PANOSE;ALPHA-D-GLC-[1->6]-ALPHA-D-GLC-[1->4]-D-GLC;4-ALPHA-ISOMALTOSYLGLUCOSE;PANOSE;O-ALPHA-D-GLUCOPYRANOSYL-(1->6)-O-ALPHA-D-GLUCOPYRANOSYL-(1->4)-D-GLUCOSE;O-ALPHA-D-GLUCOPYRANOSYL(1->6)-O-ALPHA-D-GLUCOPYRANOSYL(1->4)-ALPHA-D-GLUCOPYRANOSE;PANOSE 97+%
• CAS NO: 25193-53-7
• Molecular Formula: C18H32O16
• Molecular Weight: 504.44
• EINECS: 251-500-2
• Mol File: 25193-53-7.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: PANOSE(CAS DataBase Reference)
• NIST Chemistry Reference: PANOSE(25193-53-7)
• EPA Substance Registry System: PANOSE(25193-53-7)

Safety Data

• WGK Germany: 3
• F: 3
• Hazardous Substances Data: 25193-53-7(Hazardous Substances Data)

Upstream product

• 69-79-4 D-maltose 
• 57-50-1 Sucrose 
• 13257-24-4 6²-O-α-maltosylmaltose 
• 528-50-7 cellobiose 
• 63-42-3 D-(+)-lactose 

Downstream Products

• 50-99-7 D-glucose 

Relevant articles and documents

-

-

Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses

The present invention has objects to provide a glucan useful as water-soluble dietary fiber, its preparation and uses. The present invention solves the above objects by providing a branched α-glucan, which is constructed by glucose molecules and characterized by methylation analysis as follows: (1) Ratio of 2,3,6-trimethyl-1,4,5-triacetyl-glucitol to 2,3,4-trimethyl-1,5,6-triacetyl-glucitol is in the range of 1:0.6 to 1:4;(2) Total content of 2,3,6-trimethyl-1,4,5-triacetyl-glucitol and 2,3,4-trimethyl-1,5,6-triacetyl-glucitol is 60% or higher in the partially methylated glucitol acetates;(3) Content of 2,4,6-trimethyl-1,3,5-triacetyl-glucitol is 0.5% or higher but less than 10% in the partially methylated glucitol acetates; and(4) Content of 2,4-dimethyl-1,3,5,6-tetraacetyl-glucitol is 0.5% or higher in the partially methylated glucitol acetates; a novel α-glucosyltransferase which forms the branched α-glucan, processes for producing them, and their uses.

COMBINED USE OF DIPEPTIDYL PEPTIDASE IV INHIBITOR COMPOUND AND SWEETENER

The present invention provides a novel therapeutic or preventive method, a pharmaceutical composition and use thereof, that exhibit superior anti-obesity effects (body weight-reducing (losing) effects and/or body fat mass-reducing effects). Specifically, the present invention provides a pharmaceutical composition comprising the combination of a dipeptidyl peptidase 4 inhibitor and a sweetener having a GLP-1 secretion-stimulating action, as well as use thereof for the manufacture of a medicament. The present invention also provides a method for treating or preventing obesity, comprising administering an effective amount of (a) a dipeptidyl peptidase 4 inhibitor and (b) a sweetener having a GLP-1 secretion-stimulating action to a patient suffering from symptoms of obesity.